In early January, Ugur Sahin, a Turkish-born immunology professor, told the board of the German biotech group he co-founded to devote the small company’s resources to tackling a new virus that had emerged in China.
1月初，土耳其出生的免疫学教授乌格•萨因(Ugur Sahin)告诉他与人联合创立的德国生物技术公司的董事会，这家小公司应该把资源投入应对在manbetx3.0 出现的一种新病毒。
您已阅读4%（295字），剩余96%（7208字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。